meglitinide (Meglitinido, Meglitinidum)
Jump to navigation
Jump to search
Indications
- treatment of diabetes mellitus type 2
Adverse effects
Mechanism of action
- hypoglycemic agent
- stimulates insulin secretion by pancreatic beta cells
Clinical trials
- no long term outcome studies[3]
More general terms
More specific terms
References
- ↑ PubChem: 41214
- ↑ Ganda OP. Review: meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown. ACP J Club. 2007 Nov-Dec;147(3):65 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17975867
- ↑ 3.0 3.1 3.2 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015